#MODERNA News

FEED

Novavax says still faces strong headwinds, 2024 sales flat to lower

finance.yahoo.com COVID-19 vaccine maker Novavax on Wednesday said it still faces significant financial difficulties and expects revenue this year to be flat or lower as it works to pick up…

Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short

investorplace.com These companies each saw big moves in their share price after their latest earnings prints Earnings season for the fourth quarter of calendar 2023 is coming to a close.…

Novavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share

finance.yahoo.com COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share…

We're Gonna Need Another Pandemic!!

zerohedge.com We're Gonna Need Another Pandemic!! Zoom Video Communications, the company that rose to fame during the early days of the pandemic, ended fiscal 2024 on a strong note,…

Pandemic Winners Struggle in the Post-Pandemic World

statista.com Zoom Video Communications, the company that rose to fame during the early days of the pandemic, ended fiscal 2024 on a strong note, reporting results for its fourth fiscal…

Study Finds Hearing And Balance Disorders Among COVID-19 Vaccinated

zerohedge.com Study Finds Hearing And Balance Disorders Among COVID-19 Vaccinated Authored by Naveen Athrappully via The Epoch Times (emphasis ours), More cases of hearing and balance…

A Host Of Notable COVID-19 Vaccine Adverse Events, Backed By Evidence

zerohedge.com A Host Of Notable COVID-19 Vaccine Adverse Events, Backed By Evidence Authored by Marina Zhang via The Epoch Times (emphasis ours), (Illustration by The Epoch Times,…

Moderna downgraded, Gap upgraded: Wall Street's top analyst calls

finance.yahoo.com The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by…

Column: The only thing voters liked less than Ron DeSantis' anti-woke crusade was Ron DeSantis

latimes.com Sunday was a tough day for those, like me, who get their entertainment jollies by watching losers try to redeem themselves. I’m not talking only about the Buffalo Bills, the…

Moderna Moves to Maintain its mRNA Momentum

thedailyupside.com Moderna is in vaccine purgatory. With its Covid-19 vaccine so last year and its RSV vaccine — widely expected to receive approval from the US Food and Drug Administration…

Is Moderna Stock A Buy After Surprise Profit Sends Shares Flying?

investors.com Moderna stock soared on a strong fourth-quarter report that included unexpected earnings. Is MRNA stock a buy or a sell right now? The post Is Moderna Stock A Buy After…

Why Moderna Stock Is Jumping Today

fool.com Shares of Moderna (MRNA 13.53%) were jumping 9.5% higher as of 11:09 a.m. ET on Thursday after rising as much as 10% earlier in the day. The gain came after the biotech…

Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment

benzinga.com Pfizer Inc PFE is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates…

Moderna CEO: 2024 is year of growth, with 2023 transition in rearview

aol.com posted a surprise beat in its full-year 2023 earnings, with its COVID-19 vaccine sales topping $6.8 billion, just above the company's guidance of $6 billion. The full-year…

Why Is Moderna Stock Trading Higher Today?

benzinga.com Moderna Inc MRNA shares are trading higher after the company reported fourth-quarter 2023 revenues of $2.81 billion in Spikevax (COVID-19 vaccine), beating the consensus of…

Moderna Surges After Covid Vaccine-Maker Surprises With Fourth-Quarter Profit

investors.com stock surged Thursday after the Covid vaccine-maker beat Wall Street's quarterly expectations, including turning around a surprise profit. During the December quarter,…

Moderna’s stock pops after surprise quarterly profit, even as COVID sales continue to slide

marketwatch.com Moderna Inc. shares MRNA, jumped more than 7% premarket on Thursday after the company reported a surprise fourth-quarter profit, even as its COVID product sales continue to…

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

cnbc.com Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only…

Moderna Stock Jumps on Surprise Profit, Sales Ahead of Expectations

barrons.com Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts’ expectations.

Moderna reports surprise profit, sets out road map for RSV vaccine

finance.yahoo.com Moderna on Thursday reported a surprise fourth-quarter profit, helped by cost cutting and some deferred payments, and the vaccine maker set out a commercial roadmap for its…

Stock market today: Live updates

cnbc.com Traders on the floor of the New York Stock Exchange on Aug. 4, 2022. S&P 500 futures rose early Thursday, boosted by a jump in Nvidia shares as the chip giant posted record…

COVID Vaccine mRNA Can 'Spread Systemically' To Placenta And Infants Of Women Vaccinated During Pregnancy

zerohedge.com COVID Vaccine mRNA Can 'Spread Systemically' To Placenta And Infants Of Women Vaccinated During Pregnancy Authored by Megan Redshaw via The Epoch Times (emphasis ours), A…

Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus

benzinga.com Moderna Inc MRNA will be reporting its fourth-quarter earnings on Feb. 22. Wall Street expects a negative 99 cents in EPS and $2.53 billion in revenues as the company…

Earnings Analysis: Buy or Watch for Gains?

entrepreneur.com Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19…

Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe

investorplace.com These underperformers could require layoffs to reduce costs has called 2023 “the year of the layoffs.” As the news organization pointed out recently, it started badly in…

American stocks loiter near an all-time high

economist.com It is the first trading day of the year. The stockmarket opens a whisker away from an all-time high. American equities have soared over the past 12 months, up by around 25%,…

The Entire Business World on a Single Page. Free to Use →